Under typical conditions, this investment vehicle commits a predominant portion—no less than 95%—of its total assets to American Depositary Receipts (ADRs) representing GSK plc. It notably avoids direct investment in the company's underlying shares. Such a focused approach means the fund operates as a non-diversified portfolio.